151 related articles for article (PubMed ID: 24769650)
1. Vulvovaginal pyoderma gangrenosum secondary to rituximab therapy.
Dixit S; Selva-Nayagam P; Hamann I; Fischer G
J Low Genit Tract Dis; 2015 Jan; 19(1):e6-9. PubMed ID: 24769650
[TBL] [Abstract][Full Text] [Related]
2. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
3. Superficial granulomatous pyoderma of the vulva in a patient receiving maintenance rituximab (MabThera) for lymphoma.
Walsh M; Leonard N; Bell H
J Low Genit Tract Dis; 2011 Apr; 15(2):158-60. PubMed ID: 21169869
[TBL] [Abstract][Full Text] [Related]
4. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
Dasanu CA; Bockorny B; Alexandrescu DT
J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
[TBL] [Abstract][Full Text] [Related]
5. Pyoderma gangrenosum.
Tan WC; Ong CK; Lo KS; Leong KN
Med J Malaysia; 2007 Aug; 62(3):251-3. PubMed ID: 18246920
[TBL] [Abstract][Full Text] [Related]
6. A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab.
Donmez S; Pamuk ON; Gedik M; A K R; Bulut G
Int J Rheum Dis; 2014 May; 17(4):471-5. PubMed ID: 24460826
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum associated with biphenotypic acute leukemia.
Asai M; Aragane Y; Kawada A; Shimada T; Kanamaru A; Yamada H; Tezukam T
J Am Acad Dermatol; 2001 Mar; 44(3):530-1. PubMed ID: 11209130
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
Baglieri F; Scuderi G
Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum Preceding the diagnosis of systemic lupus erythematosus.
Waldman MA; Callen JP
Dermatology; 2005; 210(1):64-7. PubMed ID: 15604550
[TBL] [Abstract][Full Text] [Related]
10. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases.
Satoh M; Yamamoto T
J Dermatol; 2013 Oct; 40(10):840-3. PubMed ID: 24033392
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum adverse event with Rituximab use: A postmarketing pharmacovigilance analysis.
Aggarwal P
Dermatol Ther; 2020 Mar; 33(2):e13221. PubMed ID: 31925868
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic Pyoderma Gangrenosum as a Novel Manifestation of the HIV Immune Reconstitution Inflammatory Syndrome: A Report of Three Cases.
Nambudiri VE; Kersellius R; Harp J; Maniar JK; Maurer TA
J Assoc Physicians India; 2015 Jul; 63(7):72-6. PubMed ID: 26731836
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum.
Jiang YY; Li J; Li Y; Wang Q; Liu S; Fang K; Qian JM; Jin HZ
Chin Med J (Engl); 2017 Nov; 130(22):2674-2679. PubMed ID: 29133754
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab-associated pyoderma gangrenosum in a patient with metastatic squamous cell carcinoma.
Tsibris H; Lian C; Ho A
Dermatol Online J; 2021 Apr; 27(4):. PubMed ID: 33999581
[TBL] [Abstract][Full Text] [Related]
15. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab.
Marzano AV; Tourlaki A; Alessi E; Caputo R
Clin Exp Dermatol; 2008 Mar; 33(2):156-9. PubMed ID: 18021268
[TBL] [Abstract][Full Text] [Related]
16. Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?
Adişen E; Oztaş M; Gürer MA
Dermatology; 2008; 216(2):163-5. PubMed ID: 18216480
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum and high titer serum anti-CCP2 antibodies.
Das SK; Banerjee N; Khaskil S; Mukherjee SS
JNMA J Nepal Med Assoc; 2012; 52(185):36-9. PubMed ID: 23279772
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia.
Montoto S; Bosch F; Estrach T; Blade J; Nomdedeu B; Nontserrat E
Leuk Lymphoma; 1998 Jun; 30(1-2):199-202. PubMed ID: 9669691
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum: a clinical manifestation of difficult diagnosis.
Santos M; Talhari C; Rabelo RF; Schettini AP; Chirano CA; Talhari S
An Bras Dermatol; 2011; 86(1):153-6. PubMed ID: 21437541
[TBL] [Abstract][Full Text] [Related]
20. [Pyoderma gangrenosum: report of 11 cases].
López de Maturana D; Amaro P; Aranibar L; Segovia L
Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
